For many years, type 2 diabetes was described as a condition that only ever progresses. Today, researchers and diabetes organisations recognise that some people can bring their blood glucose back into the non-diabetic range and keep it there without glucose-lowering medication. This is called remission.
But remission has a precise definition, it doesn't happen for everyone, and it isn't the same as a cure. This article explains what the research says, with a focus on diet, so you can have a more informed conversation with your healthcare team.
A quick refresher: how type 2 diabetes is diagnosed
According to the American Diabetes Association (ADA) 2026 Standards of Care, diabetes can be diagnosed with any of these results, usually confirmed by a second test [1]:
- HbA1c (A1C) of 6.5% or higher (48 mmol/mol or higher).
- Fasting plasma glucose of 126 mg/dL (7.0 mmol/L) or higher.
- 2-hour plasma glucose of 200 mg/dL (11.1 mmol/L) or higher during an oral glucose tolerance test.
Type 2 diabetes accounts for 90–95% of all diabetes cases [1]. It involves insulin resistance together with insufficient insulin secretion. The ADA notes that insulin resistance may improve with weight reduction, physical activity and/or medication, but is seldom restored to normal, and that intensive lifestyle interventions and/or metabolic surgery can lead to diabetes remission [1].
What does "remission" actually mean?
In 2021, an international expert group convened by the ADA proposed a common definition [2]. Remission is defined as an HbA1c below 6.5% (48 mmol/mol) measured at least 3 months after stopping glucose-lowering medication [2].
The group chose "remission" rather than "cure" or "reversal" on purpose. Blood glucose can rise again, so people in remission still need regular check-ups [2]. The report also acknowledged that the long-term benefits and risks of achieving remission aren't yet fully understood [2].
What does the research say about low-carb diets?
A 2021 systematic review and meta-analysis in The BMJ looked at 23 randomised trials (1,357 participants) of low-carbohydrate and very-low-carbohydrate diets in adults with type 2 diabetes [3]. It defined low-carb as less than 130 g of carbohydrate per day, or less than 26% of a 2,000 kcal diet, and very-low-carb as less than 10% of calories from carbohydrate [3].
The main findings:
- At 6 months, remission (HbA1c below 6.5%) was more common with low-carb diets: 57% (76 of 133 people) versus 31% (41 of 131) on control diets [3].
- When remission was defined more strictly, as HbA1c below 6.5% without medication, the effect was smaller and not statistically significant [3].
- Remission was markedly lower in studies that included people using insulin [3].
- At 12 months, remission data were sparse, and benefits for weight, triglycerides and insulin sensitivity had diminished [3].
The authors concluded, based on moderate- to low-certainty evidence, that people who stick to a low-carb diet for six months may experience remission without adverse consequences. They also noted continuing debate about the definition of remission and about the long-term safety and satisfaction of these diets [3].
What the ADA 2026 Standards say about eating patterns
The ADA's 2026 guidance on health behaviours states that there is no single ideal mix of carbohydrate, protein and fat for everyone with diabetes [5]. Reducing overall carbohydrate intake can be considered for some adults with diabetes, and very-low-carbohydrate eating patterns show the clearest HbA1c reductions in the short term (under 6 months), with smaller differences after a year [5]. Long-term sustainability is a recognised challenge [5].
In practice, that means the eating plan should be individualised, considering preferences, culture, medications and other health conditions.
Sugar sources and liver fat
Fat build-up in the liver often goes hand in hand with insulin resistance. A 2022 meta-analysis of 51 controlled trials (2,059 participants) looked at fructose-containing sugars from different foods and markers of non-alcoholic fatty liver disease [4].
The clearest signal came from sugar-sweetened beverages. When sugary drinks added excess calories on top of the diet, liver fat increased substantially [4]. In trials where sugars replaced other macronutrients without adding calories, no effect was seen [4]. Evidence for other food sources, such as whole fruit, was less certain [4].
The practical message: cutting down on sugary drinks is one of the simplest changes with good evidence behind it.
Important safety notes
Changing your diet while taking glucose-lowering medication, especially insulin or sulfonylureas, can lower blood glucose quickly and may require medication adjustments. Please don't stop or change any medication on your own. Talk to your doctor before starting a low-carb or very-low-calorie plan, and agree how you'll monitor your glucose.
Remission is not a pass/fail test. Any improvement in blood glucose, weight, blood pressure or fitness is worthwhile, whether or not it meets the formal definition.
Practical takeaways
- Remission means an HbA1c below 6.5% (48 mmol/mol) at least 3 months after stopping glucose-lowering medication [2].
- The ADA recognises that intensive lifestyle changes and/or metabolic surgery can lead to remission [1].
- Low-carb diets increased remission at 6 months in trials, but the effect weakened at 12 months and with stricter definitions [3].
- There is no single ideal diet for diabetes; plans should be personalised [5].
- Limiting sugar-sweetened drinks may help reduce liver fat [4].
- Always involve your healthcare team before changing your diet or medication.
Small steps, steady progress
Whatever your goal, lasting change comes from routines you can keep. Viivaa helps you build healthy habits one small step at a time, so progress feels steady and sustainable.
This article is for general information only and isn't medical advice. If you have type 2 diabetes, please talk to your doctor before changing your diet, activity or medication, as adjustments and monitoring may be needed.
References
- American Diabetes Association Professional Practice Committee for Diabetes. 2. Diagnosis and classification of diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S27–S49. https://doi.org/10.2337/dc26-S002
- Riddle MC, Cefalu WT, Evans PH, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. 2021;44(10):2438–2444. https://doi.org/10.2337/dci21-0034
- Goldenberg JZ, Day A, Brinkworth GD, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ. 2021;372:m4743. https://doi.org/10.1136/bmj.m4743
- Lee D, Chiavaroli L, Ayoub-Charette S, et al. Important food sources of fructose-containing sugars and non-alcoholic fatty liver disease: a systematic review and meta-analysis of controlled trials. Nutrients. 2022;14(14):2846. https://doi.org/10.3390/nu14142846
- American Diabetes Association Professional Practice Committee for Diabetes. 5. Facilitating positive health behaviors and well-being to improve health outcomes: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S89–S131. https://doi.org/10.2337/dc26-S005